2015
DOI: 10.1016/j.rec.2014.12.016
|View full text |Cite
|
Sign up to set email alerts
|

Influence of Intravenous Nitrate Treatment on Early Mortality Among Patients With Acute Heart Failure. NITRO-EAHFE Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
12
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(14 citation statements)
references
References 23 publications
(18 reference statements)
1
12
0
1
Order By: Relevance
“…None of them reported significant changes in mortality rates. A latter report that analyzed the impact of NTG administration in the ED to patients with AHF also did not observe any association with short-term survival [13]. Very recently, to assess the importance of vasodilator therapy in the management of AHF, the GALACTIC study has been conducted [4].…”
Section: Discussionmentioning
confidence: 99%
“…None of them reported significant changes in mortality rates. A latter report that analyzed the impact of NTG administration in the ED to patients with AHF also did not observe any association with short-term survival [13]. Very recently, to assess the importance of vasodilator therapy in the management of AHF, the GALACTIC study has been conducted [4].…”
Section: Discussionmentioning
confidence: 99%
“…This was observed despite the fact that the majority of patients, irrespective of the phenotype, received drugs directed to reduce congestion (diuretics and vasodilators). Currently, it is widely accepted that, while clearly improving symptoms in patients with AHF, these drugs have no impact on patient survival . Remarkably, in the current study, the presence of congestion conditioned longer hospital stay, with increases of 27% and 52% of prolonged admissions depending on the concomitant absence or presence of hypoperfusion, respectively, compared to the warm‐dry group.…”
Section: Discussionmentioning
confidence: 44%
“…In 2012, this recommendation was downgraded to Class IIa [8,10], as the scientific basis supporting its utilization seemed limited, with very few patients enrolled in randomized controlled trials evaluating Temporal trends in nitrate utilization in elderly emergency patients 7 nitrates in AHF [6,7]. Furthermore, some studies reported an absence of benefit in patients treated with nitrates [23,24], whereas others reported a significant improvement in terms of mortality and severe outcome after nitrate utilization [16,25]. A systematic review concluded that prescription of nitrates is based more on a clinical dogma than on high-quality trials, and reliable data on survival benefit are lacking [26].…”
Section: Discussionmentioning
confidence: 99%